Our Vision

To lead by empowering underserved patients and alleviating the burdens on our overwhelmed healthcare systems. We are committed to revolutionizing healthcare accessibility by providing the essential resources needed to overcome disease and enhance care equity.

Our Mission

To make genetic testing universally accessible and shorten the time to diagnosis and treatment from years to days. 

We Are a Public Benefit Coporation

A public benefit corporation (PBC) operates like any other business, aiming to make a profit, but it also has a built-in commitment to benefiting the public. Think of it as a hybrid between a regular for-profit and a non-profit company.

While traditional companies focus primarily on maximizing shareholder value, a public benefit corporation balances this goal with the mission to also positively impact society.

“To transform healthcare in underserved communities by improving access and equity through scientific and educational resources.”
— Jura Health's Public Benefit Commitment

  • Chris Moore, MBA

    CEO + Co-Founder; 20 years of experience developing and commercializing instruments, reagents, and tests within oncology and regenerative medicine at global companies like Roche, Terumo, and Exact Sciences. Board member for Spina Bifida Foundation of Colorado and Colorado ICE Soccer Club.

    LinkedIn

  • Paul Dal Pozzo, MBA

    Chief Operating Officer + Co-Founder; 20-year background in gene research, gene therapy, cell therapy, and medical device development and manufacturing. Served in multiple development and commercial leadership roles at companies like Terumo, Sartorius and Invetech.

    LinkedIn

  • Dr. Andrea Girman, MD

    Head of Patient and Provider Advocacy. Dr. Andrea Girman is a graduate of the Johns Hopkins University School of Medicine, pediatric residency program and Bloomberg School of Public Health, as well as New York’s Beth Israel Medical Center Continuum Center for Health and Healing Integrative Medicine Fellowship. She brings 20+ years of experience in specialty medical and genomic diagnostics, including Exact Sciences, Genova Diagnostics, and Scaled Microbiomics.

    LinkedIn

  • David Lyon, MBA

    Chief Business Development Officer; 15 years of experience bringing diagnostic and genomic products to market at global companies such as Illumina and Exact Sciences. Experienced entrepreneur leader with two medical device startups, including one innovation award from the NIH.

    LinkedIn